China · Biotechnology startup
China · Sciwind Biosciences
Sciwind Biosciences is a drug research and development company for metabolic diseases.
Funding reportedLast round: Series C
Follow Sciwind Biosciences and see its new rounds in your feed. Start following
What company datasets say Sciwind Biosciences raised
Funding, as reported
Reported in all136.3Min the source's currency
Rounds3
Last roundSeries C
Last round dateOct 2021
Investors listed8
Biotechnology in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Sciwind Biosciences in front of investors. Or tell us what we have wrong.